Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changing climate shifts timing of European floods.
Blöschl G, Hall J, Parajka J, Perdigão RAP, Merz B, Arheimer B, Aronica GT, Bilibashi A, Bonacci O, Borga M, Čanjevac I, Castellarin A, Chirico GB, Claps P, Fiala K, Frolova N, Gorbachova L, Gül A, Hannaford J, Harrigan S, Kireeva M, Kiss A, Kjeldsen TR, Kohnová S, Koskela JJ, Ledvinka O, Macdonald N, Mavrova-Guirguinova M, Mediero L, Merz R, Molnar P, Montanari A, Murphy C, Osuch M, Ovcharuk V, Radevski I, Rogger M, Salinas JL, Sauquet E, Šraj M, Szolgay J, Viglione A, Volpi E, Wilson D, Zaimi K, Živković N. Blöschl G, et al. Among authors: castellarin a. Science. 2017 Aug 11;357(6351):588-590. doi: 10.1126/science.aan2506. Science. 2017. PMID: 28798129 Free article.
Changing climate both increases and decreases European river floods.
Blöschl G, Hall J, Viglione A, Perdigão RAP, Parajka J, Merz B, Lun D, Arheimer B, Aronica GT, Bilibashi A, Boháč M, Bonacci O, Borga M, Čanjevac I, Castellarin A, Chirico GB, Claps P, Frolova N, Ganora D, Gorbachova L, Gül A, Hannaford J, Harrigan S, Kireeva M, Kiss A, Kjeldsen TR, Kohnová S, Koskela JJ, Ledvinka O, Macdonald N, Mavrova-Guirguinova M, Mediero L, Merz R, Molnar P, Montanari A, Murphy C, Osuch M, Ovcharuk V, Radevski I, Salinas JL, Sauquet E, Šraj M, Szolgay J, Volpi E, Wilson D, Zaimi K, Živković N. Blöschl G, et al. Among authors: castellarin a. Nature. 2019 Sep;573(7772):108-111. doi: 10.1038/s41586-019-1495-6. Epub 2019 Aug 28. Nature. 2019. PMID: 31462777
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
The digital child: A cross-sectional survey study on the access to electronic devices in paediatrics.
Cerimoniale G, Dalpiaz I, Becherucci P, Malorgio E, Ceschin F, Rosati GV, Ragni G, Minardo G, Brambilla P, Gambotto S, Bottaro G, Tucci PL, Chiappini E; Scientific Working Group of Italian Society of Paediatric Primary Care. Cerimoniale G, et al. Acta Paediatr. 2023 Aug;112(8):1792-1803. doi: 10.1111/apa.16817. Epub 2023 May 17. Acta Paediatr. 2023. PMID: 37341150
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials.
Xue K, Hua P, Maguire MG, Daniel E, Jaffe GJ, Grunwald JE, Ying GS; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group. Xue K, et al. Ophthalmol Retina. 2023 Jul;7(7):564-572. doi: 10.1016/j.oret.2023.02.008. Epub 2023 Feb 19. Ophthalmol Retina. 2023. PMID: 36803692 Clinical Trial.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.
Silva PS, Marcus DM, Liu D, Aiello LP, Antoszyk A, Elman M, Friedman S, Glassman AR, Googe JM, Jampol LM, Martin DF, Melia M, Preston CM, Wykoff CC, Sun JK; DRCR Retina Network. Silva PS, et al. JAMA Ophthalmol. 2022 Oct 1;140(10):936-945. doi: 10.1001/jamaophthalmol.2022.3130. JAMA Ophthalmol. 2022. PMID: 35980610 Free PMC article.
78 results